Summit Partners Growth Equity Fund IX-A, L.P.'s Form 4 filing
LifeStance Health Group, Inc.LFST · filed May 29, 2024
- Accession no.
- 0000950170-24-066078
- Filed
- May 29, 2024, 5:19 PM ET
- Trade date
- May 24, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $22.4M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Summit Partners Growth Equity Fund IX-A, L.P.CIK 0001634415 | 10% Owner |
| Summit Partners Growth Equity Fund IX-B, L.P.CIK 0001634426 | 10% Owner |
| Summit Investors Ge IX/VC IV, LLCCIK 0001654074 | 10% Owner |
| Summit Partners Entrepreneur Advisors Fund II, L.P.CIK 0001660981 | 10% Owner |
| Summit Investors Ge IX/VC IV (UK), L.P.CIK 0001846709 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2024 | Common Stock | SSaleDisposed | −3,802,345 | $5.89 | −$22,395,812.05 | 41,932,358 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.